Fintech Profile: Delio

Fintech Profile: Delio

Summary

Delio provides an innovative white-label platform for private assets that enables financial institutions and organizations to enhance their offering by connecting private deal flow with HNW capital.

Scope

The new report provides information and insights into Delio, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and target market
- Information on funding, partnerships, and awards it received
- Biography of top management.

Reasons to buy

- Gain insights into Delios business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its target market and opportunities.

Overview
Product Market Mix
Growth & Impact
FinTrack Assessment
Key People
Appendix

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available